• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

89
11
11
3
3

COUNTRY

11
3
1

CATEGORIES

  • 162
  • 59
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

5
9
164
172

PUBLISHED

142
142
147
172

PRODUCT TYPE

167
3
2

Search "Hospira Generics Company Intelligence Report" returned 172 results.

Hospira, Inc. (HSP) - Product Pipeline Analysis, 2014 Update

Summary Hospira, Inc. (Hospira) is a global specialty pharmaceutical and medication delivery company. The company undertakes the development, manufacturing, and marketing of products that help improve...

July 2014
FROM

Hospira Inc - Strategy and SWOT Report

Hospira Inc - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

November 2014
FROM

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence...

December 2012
FROM

Hospira Inc - SWOT, Strategy and Corporate Finance Report

Hospira Inc - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

January 2013
FROM

Phenylephrine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

August 2015

The Pharmaceutical Market: USA

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting...

May 2012
FROM

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

February 2015
FROM
Generics/Biosimilars Collection Generics/Biosimilars Collection - Product Thumbnail Image

Generics/Biosimilars Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

July 2012
FROM

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Anemia-API Insights

Summary Anemia-API Insights, 2015 report provides Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United...

August 2015
FROM

Moderate Pain-API Insights

Summary Moderate Pain-API Insights, 2015 report provides Moderate Pain drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea...

August 2015
FROM

Phenylephrine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

August 2015

Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

August 2015
FROM

Competitor Analysis: G-CSF and GM-CSF

he present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets...

April 2013
FROM

Moderate Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Moderate Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

August 2015
FROM

Pneumonia-API Insights

Summary Pneumonia-API Insights, 2015 report provides Pneumonia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the...

August 2015
FROM

Bronchitis-API Insights

Summary Bronchitis-API Insights, 2015 report provides Bronchitis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on...

August 2015
FROM

Respiratory Tract Infections-API Insights

Summary Respiratory Tract Infections-API Insights, 2015 report provides Respiratory Tract Infections drugs marketed details and API Manufacturers details across the globe along with the location....

August 2015
FROM

Upper Respiratory Tract Infections -API Insights

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large...

August 2015
FROM
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.